Bio-Rad Laboratories Inc (NYSE:BIO)
$ 380.03 +3.57 (+0.95%) Market Cap: 10.09 Bil Enterprise Value: 9.84 Bil PE Ratio: 46.06 PB Ratio: 1.42 GF Score: 70/100

Bio Rad Laboratories Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 12:30PM GMT
Release Date Price: $281.05 (-0.27%)
Dan Leonard
RBC Capital Markets - Analyst

I'm Dan Leonard, the life science tools and diagnostics analyst at RBC. And we're thrilled to have with us from Bio-Rad, Roop Lakkaraju, CFO; and Ruben Argueta from Investor Relations. Thank you both for joining.

Roop Lakkaraju
Bio Rad Laboratories Inc - Chief Financial Officer, Executive Vice President

Thanks for having us, Dan. Appreciate it.

Questions & Answers

Dan Leonard
RBC Capital Markets - Analyst

So we've got some ground to cover in only 25 minutes to do it, I thought, Roop, to set the table, if you could just reflect back on your recently reported quarter, what worked, what were the challenges?

Roop Lakkaraju
Bio Rad Laboratories Inc - Chief Financial Officer, Executive Vice President

Yes. We reported first quarter results at the end of April. Obviously, it's a dynamic environment and markets continue to evolve. I think for us, maybe I'll highlight a few different things. Number one, when I look at where

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot